Form 4: Insulet Director Timothy Stonesifer Receives Annual Equity Award of Restricted Stock Units

Insulet Corporation's Director, Timothy C. Stonesifer, was granted 778 restricted stock units as part of an annual equity award, vesting on April 30, 2026.

Summary

• Timothy C. Stonesifer, a Director of Insulet Corp (PODD), received an annual equity award on May 22, 2025.
• The award consists of 778 restricted stock units (RSUs), which will be settled in shares of common stock on a one-for-one basis.
• These RSUs were granted at a price of $0, indicating an award rather than a purchase.
• The 778 RSUs are scheduled to vest in full on April 30, 2026.
• Following this transaction, Mr. Stonesifer's direct beneficial ownership of Insulet common stock increased to 3,629 shares.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects a routine equity award to a director, aligning their interests with shareholders. It does not indicate any negative operational or financial news and is a standard compensation practice.

Positives

• The grant of 778 restricted stock units to Director Timothy C. Stonesifer aligns his interests with those of shareholders, as the value of the award is tied to the company's stock performance.
• The award is part of an annual equity compensation plan, indicating a standard practice for director remuneration and a commitment to long-term incentives.

Negatives

• No direct negatives are apparent from this Form 4 filing, as it reports a routine equity award to a director rather than a sale or adverse event.

Risks

• No specific risks are detailed within this Form 4 filing, which primarily reports an insider transaction and does not provide information on operational or financial risks.

Future Outlook

The 778 restricted stock units granted to Director Timothy C. Stonesifer are scheduled to vest in full on April 30, 2026, indicating a future equity distribution and continued alignment of interests.

Management Comments

• No direct management comments or quotes are provided in this Form 4 filing, which is a transactional report of insider ownership changes.

Industry Context

The granting of restricted stock units to directors is a common practice across various industries, including medical technology, to incentivize long-term commitment and align leadership interests with shareholder value. This filing reflects a routine compensation event for a public company director, consistent with standard corporate governance practices.

Comparison to Industry Standards

• This Form 4 filing reports a standard equity award to a director, which is a common compensation practice across publicly traded companies, including those in the medical device and healthcare technology sectors.
• While the specific value of the award would require comparison to compensation disclosures in proxy statements (DEF 14A) of peer companies like Dexcom (DXCM) or Tandem Diabetes Care (TNDM), the mechanism of granting RSUs for director compensation is a widely adopted industry standard.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings or regulatory matters are mentioned in this Form 4 filing.

Related Party Transactions

• The reported transaction is an equity award of 778 restricted stock units to Timothy C. Stonesifer, a Director of Insulet Corp, which constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• **Shareholders:** The equity award to a director aligns management's long-term interests with shareholder value, potentially fostering sustained growth and performance.
• **Employees, Customers, Suppliers, Creditors:** No direct impact is indicated for these stakeholders by this specific filing, as it is a routine insider compensation report.

Next Steps

• The 778 restricted stock units granted to Timothy C. Stonesifer will vest in full on April 30, 2026, at which point they will be settled in shares of Insulet common stock.

Key Dates

Keywords

Insulet Corp, PODD, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Award, Director Compensation, Timothy C. Stonesifer